This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Reinsurance Group (RGA) Rides on Steady Top-Line Improvement
by Zacks Equity Research
Product-line expansion, robust revenues, improved investment results and strong capital position aid Reinsurance Group (RGA) to surface as a prospective choice for yield-seeking investors.
Is Manulife Financial (MFC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
American Equity's (AEL) Annuity Business Continues to Shine
by Zacks Equity Research
Solid annuity business, better investment results and capital strength aid American Equity (AEL) to emerge as a prospective choice for yield-seeking investors.
Torchmark (TMK) Continues to Benefit from Premium Growth
by Zacks Equity Research
Torchmark (TMK) continues to gain from premium growth and strong segmental performances.
Why You Should Add Manulife Financial (MFC) to Your Portfolio
by Zacks Equity Research
Manulife Financial (MFC) promises better reward for investors banking on operational excellence.
Manulife Financial (MFC): The Perfect Mix of Value and Rising Earnings Estimates?
by Zacks Equity Research
Manulife Financial (MFC) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Should Value Investors Buy Manulife Financial (MFC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Manulife Financial (MFC) Q3 Earnings Rise on Business Growth
by Zacks Equity Research
Solid segmental performances across Asia, United States plus Global Wealth and Asset Management as well as higher APE sales and AUM drive Manulife Financial's (MFC) Q3 performance.
Why Manulife (MFC) Might Surprise This Earnings Season
by Zacks Equity Research
Manulife (MFC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for FGL Holdings (FG) This Earnings Season?
by Zacks Equity Research
FGL Holdings' (FG) Q3 is likely to be aided by a compelling portfolio of life and annuity products.
Why Manulife (MFC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Manulife (MFC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks.com featured highlights include: MGM, Vipshop, Manulife, J. Alexander's and Verso
by Zacks Equity Research
Zacks.com featured highlights include: MGM, Vipshop, Manulife, J. Alexander's and Verso
7 Low Price-to-Sales Stocks to Buy for Solid Profits
by Zacks Equity Research
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by the company.
Why Manulife Financial (MFC) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Manulife Financial (MFC) have what it takes? Let's find out.
Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman
by Zacks Equity Research
Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman
5 Solid High Dividend Value ETFs & Stocks to Buy Now
by Sweta Killa
Nothing seems a better strategy than picking ETFs with a combination of value stocks and higher dividend yields in this kind of an environment.
5 Low Price-to-Book Stocks to Buy in a Volatile Market
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
Are You Looking for a High-Growth Dividend Stock? Manulife Financial (MFC) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Manulife Financial (MFC) have what it takes? Let's find out.
Manulife Financial on Strong Growth Graph: Apt to Hold?
by Zacks Equity Research
Manulife Financial (MFC) promises to reap better returns for investors on the back of six factors.
Why Is Manulife (MFC) Down 3.6% Since Last Earnings Report?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Research Reports with Q2 Earnings Analysis: Merck, CVS Health, CME Group & More
by Kalyan Nandy
Today's Research Daily features updated research reports on 16 major stocks, including Merck (MRK), CVS Health (CVS) and CME Group (CME).
Manulife (MFC) Q2 Earnings Improve on Solid Segment Results
by Zacks Equity Research
Double-digit core earnings growth across all operating segments as well as better net income boosts Manulife's (MFC) Q2 results.
Top Stock Reports for Alphabet, General Electric & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), General Electric (GE) and Morgan Stanley (MS).
7 Insurers Poised to Outperform in Q2 on Many Tailwinds
by Tanuka De
We zero in on seven insurance stocks, poised to exceed expectations in Q2 on the back of multiple tailwinds favoring the operating environment.
Why Is Manulife (MFC) Up 4% Since Its Last Earnings Report?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.